Furthermore, researchers also found that the variant DT388IL3 (△125-133) showed an enhanced binding to the human IL3R and greater cytotoxicity to human AML cell lines and LSCs than the wild-type DT388IL3 [42]. The gene discussed is IL3RA; the disease is acute myeloid leukemia.